Please ensure Javascript is enabled for purposes of website accessibility

Live: Coronavirus Market Crash Coverage

The Motley Fool’s live guide on what investors should do during the stock market crash and the COVID-19 pandemic.

We’ve created this page for all investors seeking advice on what they should be doing in this turbulent period. Our most important content can be found in the Editors' Picks, section.

We do believe this will all end up behind us, because we view investing as a long-term endeavor. Borrowing from Warren Buffett: "We have no idea -- and never have had -- whether the market is going to go up, down, or sideways in the near- or intermediate-term future." However, we firmly believe investors will be rewarded over the long term.

We suggest bookmarking this page as we will update our Editors' Picks periodically -- the Recent Articles section is a live feed of our latest thinking. Finally, we understand that many people are seeking epidemiological information on COVID-19. For that we strictly suggest visiting the information pages set up by the CDC and WHO.

For members of The Motley Fool's investing services, you can access all our Coronavirus market coverage at after logging in.

Recent articles


Got $1,000? 2 Stocks You Can Buy and Hold for Decades

"Forever" may just be a great holding period for these two companies.

COVID-19 vaccine and $100 bills

No Surprise Here: Moderna's Revenue Skyrockets in Q4

And it will soon soar even more thanks to the strong demand for Moderna's COVID-19 vaccine.

Vaccine vial and syringe

Is Novavax Stock a Buy?

The biotech's growth prospects still appear to clearly outweigh its risks.

Older woman about to get vaccine

1 Big Problem Ocugen Could Face That Investors Might Be Overlooking

This issue won't affect just Ocugen.

DNA with magnifying glass

Is Fulgent Genetics Still a Good Stock to Buy?

It's a volatile stock right now. But the future for genomic testing looks bright.

scales wtih coins on them

Better Buy: Disney vs. Etsy

Take a look at two of the most promising stocks on the market today.

Vaccine vials - 2 knocked over and 2 standing

Should Investors Worry About Moderna's Vaccine Delays?

The short answer: No.

COVID-19 vaccine bottles over $100 bills

2 Reasons Pfizer's COVID Vaccine Prospects Just Got Even Better

The good news keeps on coming.

COVID vaccine with microscope

What Are the Long-Term Prospects for Moderna?

The biotech's messenger RNA platform is promising. But some investors could have qualms about its current valuation.


Are Short-Sellers Right About Inovio?

This straggler in the vaccine race is still facing some struggles -- but there are a couple of bright spots.

Coronavirus model on $100 bills

Is Sorrento Therapeutics a Good Coronavirus Stock to Buy?

The biotech certainly has plenty of COVID-19 candidates in the hopper.

Physician holding a vaccine shot

Is Moderna Stock a Buy?

Here are the short- and long-term answers.

2 COVID vaccines in front of $100

Better Coronavirus Stock: Moderna or Novavax?

There's plenty to like about both of these high-flying biotech stocks.

Gloved hands holding 2 COVID vaccine bottles

Will AstraZeneca's Pain Be Johnson & Johnson's Gain?

The two big drugmakers' vaccine fortunes recently went in opposite directions.

COVID-19 vaccine

Should You Buy Ocugen Stock?

Here's why you might want to -- and why it might not be such a great idea.

COVID vaccine with dollar sign

Why Ocugen Stock Is Jumping Today

There's continued momentum from the drugmaker's big news announced earlier this month.

BetMGM Sportsbook mgm resorts source-mgm

Forget Las Vegas Sands, MGM Resorts Is a Better Casino Stock

Casinos still face strong headwinds, but this resort operator has one major defense against them.

COVID-19 coronavirus wood blocks

1 Big COVID-19 Story That Has Nothing to Do With Vaccines

But this development could be enormously important in fighting COVID-19.

Physician holding COVID vaccine and syringe

The Important Things to Know About Johnson & Johnson's COVID Vaccine

J&J's new vaccine could be important in ending the pandemic.

COVID vaccine with microscope

Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna

It's simply not an apples-to-apples comparison.